Research & Education

IASLC Strongly Supports the Introduction of the New European Tobacco Products Directive to Make Smoking Less Attractive

DENVER - The leadership of the IASLC is pleased to see the European Parliament’s decision on a new European Tobacco Products Directive and hopes to see swift adoption of the text by the Council of Ministers.

Hormone Therapy Linked to Better Survival after Lung Cancer Diagnosis in Women

DENVER – Survival among people with lung cancer has been better for women than men, and the findings of a recent study indicate that female hormones may be a factor in this difference.

Novel Assay Developed for Detecting ALK Rearrangement in NSCLC

Technique Offers Benefit over Currently Available Methods

DENVER – Researchers have developed a novel technique for detecting ALK rearrangements in non-small cell lung cancers (NSCLCs) that is more sensitive and easier to perform than currently available techniques.

Significant Discrepancies between FISH and IHC Results for ALK Testing

Results Support Need for Combined Testing

DENVER –The findings of a recent study indicate that routine testing with both fluorescent in situ hybridization (FISH) and immunohistochemistry (IHC) may enhance the detection of ALK-positive non-small cell lung cancer (NSCLC).

High Frequency of EGFR Mutations Found in Asian Population

High Rate across all Asian Subgroups

DENVER – Adenocarcinoma histology, female sex, never-smoking status, and Asian ethnicity have been considered the most important factors associated with EGFR mutations in non-small cell lung cancer and response to EGFR inhibitors.

Clinical Trial Success Influenced by Biomarker- and Receptor-Targeted Therapies in NSCLC

DENVER – Over the past decade, a great clinical focus has been directed at developing new and innovative therapies for advanced non-small cell lung cancer (NSCLC).